CME Course: Acting Rapidly With Pharmacotherapy – Step 2 In Hypertension Control
|Last Modified||September 21, 2023|
|Audience||Healthcare Professionals ||
|Topics||Act Rapidly ||
|Resource Type||Video / Webinar | Weblink|
Activity has been approved for CME/CE credit
Target Audience: Physicians, Nurse Practitioners, Nurses, Other –Physician Assistants, Quality Improvement Staff, Clinical Care Staff, and Medical Assistants
This activity trains physicians, providers and other care team members registered for the AHA/AMA joint Target: BP™ initiative, on the “Act Rapidly” component of the AMA MAP Quality Improvement Framework. MAP stands for Measure Accurately, Act Rapidly, and Partner with Patients.
The goal of acting rapidly is to reduce therapeutic inertia and improve blood pressure in patients whose BP is uncontrolled. This is accomplished through a combination of using an evidence-based treatment protocol, using single-pill combination antihypertensive medications and following up frequently with patients until BP control is achieved.
At the completion of this course, the learner will be able to:
- Define therapeutic inertia, list contributing factors, and impact on BP control.
- Describe importance of treatment intensification on improving blood pressure control.
- Review strategies to address therapeutic inertia and increase treatment intensification.
Act Rapidly - to ensure an effective management
Estimated Time to Complete the Educational Activity
Brent Egan, MD, FAHA
Cardiovascular Disease Prevention, improving Health Outcomes
American Medical Association
ORIGINAL RELEASE DATE: 11/11/2021
TERMINATION DATE: 11/10/2024
LAST REVIEW DATE: November 2021
ACCREDITATION TERMS: Joint Accreditation: 11/11/2021 – 11/10/2024